Assignee
BIOMARCK PHARMACEUTICALS LTD
US·9 granted patents·5 pending applications·32 citations·filing 2006–2023
Top patents by PatentIndex Score
14 records- 0190US9408886B2Inhibitors of metastasisBIOMARCK PHARMACEUTICALS LTD·Filed 2014·Granted Aug 9, 2016·5 cites·23 claims
- 0289US7524926B2Mucin hypersecretion inhibitors and methods of useBIOMARCK PHARMACEUTICALS LTD·Filed 2006·Granted Apr 28, 2009·10 cites·55 claims
- 0387US10011636B2Inhibitors of metastasisBIOMARCK PHARMACEUTICALS LTD·Filed 2016·Granted Jul 3, 2018·3 cites·22 claims
- 0484US10683328B2Inhibitors of metastasisBIOMARCK PHARMACEUTICALS LTD·Filed 2018·Granted Jun 16, 2020·1 cites·12 claims
- 0584US2023293629A1Methods for attenuating release of inflammatory mediators and peptides useful thereinBIOMARCK PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 0682US7544772B2Methods for regulating inflammatory mediators and peptides useful thereinBIOMARCK PHARMACEUTICALS LTD·Filed 2006·Granted Jun 9, 2009·8 cites·36 claims
- 0779US9598463B2Mucin hypersecretion inhibitors and methods of useBIOMARCK PHARMACEUTICALS LTD·Filed 2014·Granted Mar 21, 2017·2 cites·13 claims
- 0878US8907056B2Mucin hypersecretion inhibitors and methods of useBIOMARCK PHARMACEUTICALS LTD·Filed 2013·Granted Dec 9, 2014·2 cites·16 claims
- 0976US2021260154A1Methods for attenuating release of inflammatory mediators and peptides useful thereinBIOMARCK PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1074US9827287B2Methods for attenuating release of inflammatory mediators and peptides useful thereinBIOMARCK PHARMACEUTICALS LTD·Filed 2015·Granted Nov 28, 2017·1 cites·9 claims
- 1174US2020138898A1Methods for attenuating release of inflammatory mediators and peptides useful thereinBIOMARCK PHARMACEUTICALS LTD·Filed 2018·Application pending·0 cites
- 1272US11466054B2Inhibitors of metastasisBIOMARCK PHARMACEUTICALS LTD·Filed 2020·Granted Oct 11, 2022·0 cites·12 claims
- 1363US2025161403A1Peptides and methods of use thereof in treating ocular disordersBIOMARCK PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 1463US2018036367A1Methods for attenuating release of inflammatory mediators and peptides useful thereinBIOMARCK PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BIOMARCK PHARMACEUTICALS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →